Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis

Clinical Rheumatology

Volumn 34, Issue 10, 2015, Pages 1713-1720

  Huang, Qing ^a   Tao, Sha Sha ^a   Zhang, Yu Jing ^a   Zhang, Chao ^a   Li, Lian Ju ^a   Zhao, Wei ^a   Zhao, Meng Qin ^a   Li, Peng ^a   Pan, Hai Feng ^a   Mao, Chen ^b   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Meta analysis; Resistin; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

RESISTIN; BIOLOGICAL MARKER; RETN PROTEIN, HUMAN;

ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; BLOOD; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION REGULATION; MALE; META ANALYSIS; MIDDLE AGED; REGRESSION ANALYSIS;

ADULT; ARTHRITIS, RHEUMATOID; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RESISTIN;

EID: 84942297589     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-2955-5     Document Type: Article

References (37)

1. Smolen JS, Aletaha D, Koeller M et al (2007) New therapies for treatment of rheumatoid arthritis. Lancet 370(9602):1861–1874
2. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 42(6937):356–361
3. Arend WP (2001) Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum 45(1):101–106
4. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772–783
5. Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409(6818):307–312
6. Holcomb IN, Kabakoff RC, Chan B et al (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19(15):4046–4055
7. Frye M, Bargon J, Lembcke B et al (2000) Differential expression of human α- and β- defensins mRNA in gastrointestinal epithelia. Eur J Clin Invest 30(8):695–701
8. Bokarewa M, Nagaev I, Dahlberg L et al (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174(9):5789–5795
9. Silswal N, Singh AK, Aruna B et al (2005) Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem Biophys Res Commun 334(4):1092–1101
10. Rho YH, Solus J, Sokka T et al (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60(7):1906–1914
11. El-Barbary AM, Hussein MS, Rageh EM et al (2011) Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid a rthritis. J Rheumatol 38(2):229–235
12. Forsblad d'Elia H, Pullerits R, Carlsten H et al (2008) Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford) 47(7):1082–1087
13. Alkady EA, Ahmed HM, Tag L et al (2009) Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients relation to disease activity. Z Rheumatol 70(7):602–608
14. Migita K, Maeda Y, Miyashita T et al (2009) The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol 24(6):698–701
15. Naime C, Ebru K, Ayşe Dicle T (2009) Plasma resistin and leptin levels in overweight and lean patients with rheumatoid arthritis. Turk J Med Sci 39(3):447–451
16. Yoshino T, Kusunoki N, Tanaka N et al (2011) Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med 50(4):269–275
17. Toussirot E, Grandclément E, Gaugler B (2013) Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. a comparative study. Front Immunol 4:453
18. Chung CP, Long AG, Solus JF et al (2009) Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 18(9):799–806
19. Tanaka N, Kusunoki N, Kusunoki Y et al (2013) Resistin is associated is with the inflammation process in patients with systemic autoimmune diseases undergoing glucocorticoid therapy: comparison with leptin and adiponectin. Mod Rheumatol 23(1):8–18
20. Baker JF, Morales M, Qatanani M et al (2011) Resistin levels in lupus and associations with disease-specific measures, insulin resisance, and coronarycalcification. J Rheumatol 38(11):2369–2375
21. Almehed K, d’Elia HF, Bokarewa M et al (2008) Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther 10(1):R15
22. De Sanctis JB, Zabaleta M, Bianco NE et al (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42(4):272–274
23. Elshishtawy H, Ibrahim SED, Helmi A et al (2012) Resistin in systemic lupus erythematosus: Relation to lupus nephritis and premature atherosclerosis. Egypt Rheumatol 34(4):137–146
24. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoidarthritis. ArthritisRheum 31(3):315–324
25. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
26. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277
27. Wells G, Shea B, O’Connell D et al (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of casecontrol studies in meta-analyses. Eur J Epidemiol 25:603–605
28. Whitlock RP, Chan S, Devereaux PJ et al (2008) Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass:a meta-analysis of randomized trials. Eur Heart J 29(21):2592–2600
29. Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13
30. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
31. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
32. Rea R, Donnelly R (2004) Resistin: an adipocyte-derived hormone. has it a role in diabetes and obesity? Diabetes Obes Metab 6(3):163–170
33. Shojima N, Sakoda H, Ogihara T et al (2002) Humoral regulation of resistin expression in 3 T3-L1 and mouse adipose cells. Diabetes 51(6):1737–1744
34. Fasshauer M, Klein J, Neumann S et al (2001) Tumor necrosis factor α is a negative regulator of resistin gene expression and secretion in 3 T3-L1 adipocytes. Biochem Biophys Res Commun 288(4):1027–1031
35. Kaser S, Kaser A, Sandhofer A et al (2003) Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309(2):286–290
36. Schäffler A, Ehling A, Neumann E et al (2003) Adipocytokines in synovial fluid. JAMA 290(13):1709–1710
37. Senolt L, Housa D, Vernerová Z et al (2007) Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66(4):458–463